ArticleJTCVS techniques2025
Three-dimensional virtual lung reconstruction in robotic segmentectomy: A safety and feasibility trial.
Article in JTCVS techniques, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Intraoperative recall of surgeon-defined 3-dimensional planning during robotic pulmonary resection: A feasibility study.JTCVS techniques · 2026Article
- Retrospective comparison of three-dimensional computed tomography bronchography and angiography-assisted indocyanine green reverse staining versus modified inflation-deflation in robotic-assisted thoracoscopic segmentectomy.Journal of thoracic disease · 2026Article
- Robotic Thoracic Surgery: Current Landscape and Future Directions.Interdisciplinary cardiovascular and thoracic surgery · 2026Review
- Beyond the single incision: quality assurance in the expanding era of segmentectomy for early-stage non-small cell lung cancer.Journal of visualized surgery · 2026Article
- Three-dimensional anatomical reconstruction as a guideline-anchored framework for choosing between lung-sparing resection and image-guided ablation in deep subsolid pulmonary nodules: a thoracic surgeon's perspective.Frontiers in oncology · 2026Article
- 3DCT reconstruction-does 3DCT improve anatomical lung resection?-a narrative review of the literature.Journal of thoracic disease · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Robotic pulmonary segmental resection is a technically challenging procedure. Near-infrared fluorescence mapping with intravascular indocyanine green dye is a valuable adjunct; however, conversion to lobectomy still occurs in up to 40% of cases. We hypothesized that the incorporation of 3-dimensional virtual lung reconstruction would result in low rates of conversion from segmentectomy to lobectomy and increased confidence in the surgical plan. Methods: A prospective single-center cohort trial was conducted to determine the safety and feasibility of this approach. Patients undergoing robotic segmentectomy for clinical stage I non-small cell lung cancer less than 3 cm were enrolled, and 3-dimensional reconstruction was performed with confidence scores assigned before and after 3-dimensional reconstruction. Adverse events, rates of conversion to lobectomy, and changes in confidence scores were recorded and analyzed. Results: A total of 79 patients were enrolled from December 2022 to April 2024, and 76 patients (96.20%) underwent surgery. Three-dimensional reconstruction was successfully performed in 88.16% (67/76) of cases, and indocyanine green dye was used in 68.66% (46/67) with no adverse events related to its use. The 30-day mortality was 1.49% (1/59). The majority of patients (80.60%; 54/67) underwent a successful segmentectomy, whereas 8.96% (6/67) of cases were converted to lobectomy after segmentectomy was started. The planned operation was modified after 3-dimensional reconstruction in 36.07% (22/61) of cases leading to a significant increase in confidence scores ( Conclusions: Three-dimensional lung reconstruction in targeted robotic segmental resection is associated with low rates of conversion to lobectomy and increased surgeon confidence. Further studies are warranted to establish the effectiveness of this technique.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.